Top Markets
#1 Black Phoenix Black Phoenix +743.63%
#2 Islamic Coin Islamic Coin +146.07%
#3 Beam Beam +32.83%
#4 THORChain THORChain +25.51%
#5 TENDIES TENDIES +19.49%
#6 THORChain Yield THORChain Yield +19.43%
#7 SAFEcoin SAFEcoin +18.45%
#8 MiL.k Alliance MiL.k Alliance +16.38%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +16.02%
#10 Bless Bless +15.60%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Clasificación en acciones #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
Precio por acción
$93.80
Última sincronización: 2025-04-28
Capitalización bursátil
$2.68B
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Aerovate Therapeutics, Inc. (AVTE)

Categoría

Healthcare
Ratio P/B de Aerovate Therapeutics, Inc. (AVTE)
Ratio P/B al August 2026 TTM: 0.37
Según los informes financieros más recientes y el precio de las acciones de Aerovate Therapeutics, Inc., el ratio P/B actual (TTM) es 0.37. Al final de 2023, el ratio P/B era 5.44.
Historial del ratio P/B de Aerovate Therapeutics, Inc. desde 2020 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
2026 (TTM) 0.37 -100.02%
2024 -1.62K -29,830.16%
2023 5.44 -3.77%
2022 5.66 238.93%
2021 1.67 -99.12%
2020 189.49 0.00%
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 1,605.27%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 1,578.22%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 897.23%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 573.68%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH